Endo International plc

Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines through excellence in development, manufacturing and commercialization. Through our operating companies – Endo Pharmaceuticals, Par Pharmaceutical and Paladin Labs – Endo is dedicated to serving patients in need. Endo commenced operations in 1997 by acquiring certain pharmaceutical products, related rights and assets from The DuPont Merck Pharmaceutical Company. Since that time, the company has expanded to include the following business segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals and International Pharmaceuticals.

Bank Name Endo International plc
Stock Exchange NASDAQ
Symbol ENDP
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region America
CEO Mr. Paul V. Campanelli
Employees 3039
Website www.endo.com
Registered Year 1920